US IPO Pipeline SEC S-1 Filings — May 13, 2026

Unanimous TMRC Board recommendation for merger as fair and in best interests, positive sentiment (9/10 materiality)

Fixed share exchange pool of 3,823,328 USAR shares for TMRC fully diluted shares, cash in lieu of fractions

Merger structure via two successive mergers making TMRC wholly owned subsidiary, targeted Q3 2026 close (vs prior SPAC name change Mar 2023)

Emerging growth company, smaller reporting company, non-accelerated filer status supports streamlined path

Regained Nasdaq Capital Market compliance on equity rule Dec 19, 2025 (post Oct 16, 2025 deficiency notice), positive trend reversal

Nasdaq Hearings Panel granted continued listing Dec 4, 2025 with conditions met, first compliance confirmation

$250M equity facility commitment over 24 months provides funding access despite 9.99% ownership cap

Merger agreement dated Mar 4, 2026 advances rare earths consolidation, higher materiality (9/10) vs Nauticus (8/10)

S-1 enables resale by selling stockholder, potential near-term liquidity vs USAR's longer Q3 timeline

100% positive sentiment vs Nauticus mixed, signals stronger conviction in transaction

Quarterly $3.5M min stockholders' equity maintained post-compliance, stable vs prior deficiencies

Merger avoids immediate dilution (fixed pool) unlike Nauticus' 103.7M shares

Registration of 103,734,440 shares for resale under $250M facility risks significant stock price declines and limited proceeds due to market conditions

Under Mandatory Panel Monitor until Dec 19, 2026 requiring quarterly $3.5M equity, prior deficiencies in MVLS/equity/net income (Oct 2025)

Merger requires majority approval of TMRC outstanding shares at special meeting, pending stockholder vote

9.99% beneficial ownership cap limits actual funding drawdown, mixed sentiment reflects execution uncertainty

Nasdaq deficiencies noted Oct 16, 2025 across multiple rules, recent regain but monitored status signals fragility

Targeted Q3 2026 closing conditional on approvals, 2+ month lag from Mar 4 agreement filing

Facility proceeds highly sensitive to stock price and volumes, potential for zero net funding

USAR no compliance issues but merger dependency vs Nauticus' ongoing monitor (6+ months)

Mixed outlook due to dilution/monitor vs USAR's positive, lower materiality edge

TMRC shareholders receive USAR shares in pool exchange, Q3 2026 close offers rare earths consolidation alpha post-approval

Unanimous recommendation positions for smooth vote, positive sentiment (9/10) undervalued vs sector M&A

$250M facility over 24 months despite risks, regained Nasdaq status enables scaling in robotics

Equity rule compliance confirmed Dec 19, 2025 (post Panel Dec 4), turnaround from 2025 deficiencies

Ex-SPAC (Inflection Point II, renamed Mar 2023) merges with TMRC for vertical integration, fixed terms reduce uncertainty

S-1 resale by selling stockholder unlocks near-term trading volume vs USAR's delayed close

Higher materiality (9/10 vs 8/10), no dilution/monitor risks positions as top pick in pipeline

Potential full delisting risk removal by Dec 19, 2026 if equity sustained, short-term catalyst

Pre-Q3 vote offers arb-like opportunity on approval odds, board fairness opinion supports

Quarterly $3.5M threshold met recently, watch for robotics demand driving upside

1/2 filings (USAR S-4) use mergers/SPAC legacies for public access (Q3 2026 close), faster/less dilutive than traditional IPOs, bullish for resource sectors like rare earths

Nauticus S-1 exemplifies $250M facilities with 100M+ share resales (24 months), mixed sentiment avg across filings due to price pressure but funds growth

50% of filings (Nauticus) show recent recovery (Dec 2025) but extended monitors (to 2026), highlights emerging co fragility vs compliant peers like USAR

50% positive (USAR 9/10 materiality) vs 50% mixed (Nauticus), driven by approval risks vs dilution, favor board-backed deals

Aggregate 103M+ shares registered + merger pools signal heavy reliance on equity/m&A for funding, implications for dilution trends in IPO pipeline

USAR closing targets cluster forward-looking events, portfolio watch for approval-driven pops in resource/tech hybrids

Monitor stockholder vote for majority approval, key to Q3 2026 merger close

Track progress post-Mar 4, 2026 agreement toward Q3 2026 target, filings updates

Quarterly $3.5M equity checks under Mandatory Panel until Dec 19, 2026 delisting risk

Watch initial sales under $250M commitment over 24 months from May 13, 2026 S-1 for dilution impact

Post-merger integration risks after wholly owned sub formation, Q3 2026

Potential declines from 103.7M share resales, monitor vs 9.99% cap effectiveness

Non-accelerated filer updates, emerging growth co milestones post-filing

Compliance with Dec 4, 2025 Hearings Panel terms through 2026 monitoring period